Keeping clinical trials moving forward and on track is imperative now more than ever as we navigate today’s challenges. Sites are eager to work and continue to support the progress of clinical trials for the benefits of subjects. Despite the pandemic, we have been able to meet 100% of enrollment targets while facilitating the closest relationship possible between sites and subjects to support decentralized trials.
In a recent study, we were successful in bringing the study to completion ahead of schedule during the pandemic using proactive planning with the sponsor and the offering of decentralized service platforms allowing the sites to continue to safely conduct the clinical trial while maintaining the highest level of quality.
I invite you to view our case study
Download our case study that highlights how we navigated this clinical trial through the 2020 environment.